No association between polymorphism in PEMT (V175M) and hepatic triglyceride content in the Dallas Heart Study.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

1. Nutrients · 2023
   Article
2. The Association between Pediatric NAFLD and Common Genetic Variants.Children (Basel, Switzerland) · 2017
   Review
3. Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamineJournal of lipid research · 2017
   Article
4. 1-Carbon Cycle Metabolites Methylate Their Way to Fatty Liver.Trends in endocrinology and metabolism: TEM · 2017
   Review
5. Genetic background in nonalcoholic fatty liver disease: A comprehensive review.World journal of gastroenterology · 2015
   Review
6. Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.Current pharmaceutical design · 2013
   Article
7. Genetic determinants of hepatic steatosis in man.Journal of lipid research · 2011
   Review
8. Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2010
   Article

Corrections and comments

• Comment on
  Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD).2005

Authors and funding

3 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as